ImmunoGen, Oxford BioTherapeutics To Collaborate To Develop Novel Antibody-Drug Conjugates

RTTNews | 954 ngày trước
ImmunoGen, Oxford BioTherapeutics To Collaborate To Develop Novel Antibody-Drug Conjugates

(RTTNews) - ImmunoGen Inc. (IMGN), a developer of antibody-drug conjugates (ADCs) for the treatment of cancer, announced Monday a multi-year collaboration to research novel, first-in-class ADCs with clinical stage oncology company Oxford BioTherapeutics (OBT), utilizing ImmunoGen's proprietary linker-payload technology directed to novel targets identified via OBT's proprietary OGAP discovery platform.

The companies will support these research and development (R&D) efforts through joint funding and by using their respective proprietary technologies.

As part of the agreement, OBT will receive an upfront payment from ImmunoGen, reflecting OBT's preclinical programs to be included in the collaboration. After antibodies generated by OBT have been coupled with ImmunoGen's proprietary linker-payload technology, each company will have the opportunity to select one or more development programs to further develop on its own.

Once a company has chosen a given program, it will be solely responsible for all R&D costs associated with that specific program.

Each company will be eligible to receive milestone payments based on the achievement of pre-specified development and regulatory milestones, as well as tiered royalties as a percentage of worldwide commercial sales, with respect to each program selected by the other company.

read more
CAC 40 Rises To Near 7-month High

CAC 40 Rises To Near 7-month High

French stocks are up in positive territory Wednesday morning, tracking positive cues from other markets in Europe, amid hopes the European Central Bank will lower interest rate, and that there will be a couple of interest rate cuts by the Federal Reserve this year. Concerns about imposition of trade tariffs by the Trump administration weigh a bit, limiting market's upside.
RTTNews | 5h 12phút trước
DAX Rises On Rate Cut Hopes, Adidas' Upbeat Results

DAX Rises On Rate Cut Hopes, Adidas' Upbeat Results

Despite lingering concerns about potential trade tariffs, German stocks are up firmly in positive territory Wednesday morning, reacting to upbeat earnings updates from Adidas, and U.S. President Donald Trump's announcement of a big investment in AI infrastructure in the United States.
RTTNews | 5h 36phút trước
Netflix Stock Gains On Upbeat Q4, Bullish Guidance

Netflix Stock Gains On Upbeat Q4, Bullish Guidance

Netflix Inc.'s shares gained around 14 percent in the after-hours trading on Tuesday and are currently up 14 percent in the pre-market activity, as the streaming video giant issued positive outlook for its first quarter and lifted fiscal 2025 view. The fourth-quarter earnings beat market estimates with significant growth. The results and outlook mainly reflected 19 million net additions...
RTTNews | 5h 38phút trước
Pound Slides Amid BoE Rate Cut Speculation

Pound Slides Amid BoE Rate Cut Speculation

The British pound weakened against other major currencies in the Asian session on Wednesday, as traders speculate a rate cut by the Bank of England (BoE) in February.
RTTNews | 5h 44phút trước
Asian Shares Mixed Amid Trump's Tariff Threats

Asian Shares Mixed Amid Trump's Tariff Threats

Asian stocks ended mixed on Wednesday, with Chinese and Hong Kong markets falling sharply after U.S. President Donald Trump threatened tariffs on the EU and China to address trade imbalances and combat fentanyl trafficking.
RTTNews | 6h 23phút trước